1227911-51-4
1227911-51-4 structure
- Name: 3-methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
- Chemical Name: 3-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole
- CAS Number: 1227911-51-4
- Molecular Formula: C14H19BN2O2
- Molecular Weight: 258.12400
- Create Date: 2018-06-13 14:21:49
- Modify Date: 2024-01-02 20:31:05
| Name | 3-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole |
|---|---|
| Synonyms |
3-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-INDAZOLE
3-methyl-6-indazoleboronic acid pinacol ester 3-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 3-METHYLINDAZOLE-6-BORONIC ACID PINACOL ESTER |
| Molecular Formula | C14H19BN2O2 |
|---|---|
| Molecular Weight | 258.12400 |
| Exact Mass | 258.15400 |
| PSA | 47.14000 |
| LogP | 2.17050 |
| Hazard Codes | Xn |
|---|---|
| HS Code | 2933990090 |
|
~88%
1227911-51-4 |
| Literature: Rhizen Pharmaceuticals SA; Incozen Therapeutics Pvt. Ltd. Patent: US2011/118257 A1, 2011 ; Location in patent: Page/Page column 98 ; |
|
~%
1227911-51-4 |
| Literature: Rhizen Pharmaceuticals SA; Incozen Therapeutics Pvt. Ltd. Patent: US2011/118257 A1, 2011 ; |
|
~%
1227911-51-4 |
| Literature: Rhizen Pharmaceuticals SA; Incozen Therapeutics Pvt. Ltd. Patent: US2011/118257 A1, 2011 ; |
|
~%
1227911-51-4 |
| Literature: Rhizen Pharmaceuticals SA; Incozen Therapeutics Pvt. Ltd. Patent: US2011/118257 A1, 2011 ; |
| Precursor 5 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |